Trial Outcomes & Findings for Saline vs. Lactated Ringers for Emergency Department IV Fluid Resuscitation (NCT NCT03133767)

NCT ID: NCT03133767

Last Updated: 2018-09-11

Results Overview

The Quality of Recovery-40 (QoR-40) is a validated instrument that quantifies patient's self-assessment of functional recovery, symptoms, and physical comfort. The QoR-40 scores range from 40 to 200 with a 200 representing a better recovery outcome. The survey consists of 40 questions scored from one to five with a Likert scale, and the total score is the sum of each question.

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

157 participants

Primary outcome timeframe

24 hours after ED visit

Results posted on

2018-09-11

Participant Flow

Participant milestones

Participant milestones
Measure
Lactated Ringers Solution
Participants in this arm will receive two liters of IV Lactated Ringer's solution during their emergency department stay Lactated Ringer Solution: 2 liters of intravenous lactated ringers solution will be administered by peripheral IV
Normal Saline Solution
Participants in this arm will receive two liters of IV 0.9% sodium chloride solution during their emergency department stay Normal Saline 0.9% Infusion Solution Bag: 2 liters of intravenous normal saline solution will be administered by peripheral IV
Overall Study
STARTED
79
78
Overall Study
COMPLETED
41
53
Overall Study
NOT COMPLETED
38
25

Reasons for withdrawal

Reasons for withdrawal
Measure
Lactated Ringers Solution
Participants in this arm will receive two liters of IV Lactated Ringer's solution during their emergency department stay Lactated Ringer Solution: 2 liters of intravenous lactated ringers solution will be administered by peripheral IV
Normal Saline Solution
Participants in this arm will receive two liters of IV 0.9% sodium chloride solution during their emergency department stay Normal Saline 0.9% Infusion Solution Bag: 2 liters of intravenous normal saline solution will be administered by peripheral IV
Overall Study
Lost to Follow-up
38
24
Overall Study
Protocol Violation
0
1

Baseline Characteristics

Saline vs. Lactated Ringers for Emergency Department IV Fluid Resuscitation

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Lactated Ringers Solution
n=41 Participants
Participants in this arm will receive two liters of IV Lactated Ringer's solution during their emergency department stay Lactated Ringer Solution: 2 liters of intravenous lactated ringers solution will be administered by peripheral IV
Normal Saline Solution
n=53 Participants
Participants in this arm will receive two liters of IV 0.9% sodium chloride solution during their emergency department stay Normal Saline 0.9% Infusion Solution Bag: 2 liters of intravenous normal saline solution will be administered by peripheral IV
Total
n=94 Participants
Total of all reporting groups
Age, Continuous
29 years
n=93 Participants
39 years
n=4 Participants
35 years
n=27 Participants
Sex: Female, Male
Female
34 Participants
n=93 Participants
24 Participants
n=4 Participants
58 Participants
n=27 Participants
Sex: Female, Male
Male
7 Participants
n=93 Participants
29 Participants
n=4 Participants
36 Participants
n=27 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Race (NIH/OMB)
Asian
3 Participants
n=93 Participants
0 Participants
n=4 Participants
3 Participants
n=27 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Race (NIH/OMB)
Black or African American
2 Participants
n=93 Participants
7 Participants
n=4 Participants
9 Participants
n=27 Participants
Race (NIH/OMB)
White
34 Participants
n=93 Participants
45 Participants
n=4 Participants
79 Participants
n=27 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants
n=93 Participants
1 Participants
n=4 Participants
3 Participants
n=27 Participants
Region of Enrollment
United States
41 participants
n=93 Participants
53 participants
n=4 Participants
94 participants
n=27 Participants

PRIMARY outcome

Timeframe: 24 hours after ED visit

The Quality of Recovery-40 (QoR-40) is a validated instrument that quantifies patient's self-assessment of functional recovery, symptoms, and physical comfort. The QoR-40 scores range from 40 to 200 with a 200 representing a better recovery outcome. The survey consists of 40 questions scored from one to five with a Likert scale, and the total score is the sum of each question.

Outcome measures

Outcome measures
Measure
Normal Saline Solution
n=53 Participants
Participants in this arm will receive two liters of IV 0.9% sodium chloride solution during their emergency department stay Normal Saline 0.9% Infusion Solution Bag: 2 liters of intravenous normal saline solution will be administered by peripheral IV
Lactated Ringers Solution
n=41 Participants
Participants in this arm will receive two liters of IV Lactated Ringer's solution during their emergency department stay Lactated Ringer Solution: 2 liters of intravenous lactated ringers solution will be administered by peripheral IV
Quality of Recovery-40 Score at 24 Hours
164.4 units on a scale
Interval 157.8 to 171.0
166.8 units on a scale
Interval 160.5 to 173.1

SECONDARY outcome

Timeframe: Immediately after fluid administration

The Quality of Recovery-40 (QoR-40) is a validated instrument that quantifies patient's self-assessment of functional recovery, symptoms, and physical comfort. The QoR-40 scores range from 40 to 200 with a 200 representing a better recovery outcome. The survey consists of 40 questions scored from one to five with a Likert scale, and the total score is the sum of each question.

Outcome measures

Outcome measures
Measure
Normal Saline Solution
n=53 Participants
Participants in this arm will receive two liters of IV 0.9% sodium chloride solution during their emergency department stay Normal Saline 0.9% Infusion Solution Bag: 2 liters of intravenous normal saline solution will be administered by peripheral IV
Lactated Ringers Solution
n=41 Participants
Participants in this arm will receive two liters of IV Lactated Ringer's solution during their emergency department stay Lactated Ringer Solution: 2 liters of intravenous lactated ringers solution will be administered by peripheral IV
Quality of Recovery-40 Score After Administration
141.6 units on a scale
Interval 133.5 to 149.7
152.6 units on a scale
Interval 145.3 to 159.9

SECONDARY outcome

Timeframe: 7 days after study enrollment

Population: Only participants that received an ED prescription and responded to the seven-day text message were included in this analysis (26 participants in the LR and 25 in the NS group).

Seven days after study enrollment, participants were asked by text message, "Have you filled any prescriptions from the emergency department?"

Outcome measures

Outcome measures
Measure
Normal Saline Solution
n=25 Participants
Participants in this arm will receive two liters of IV 0.9% sodium chloride solution during their emergency department stay Normal Saline 0.9% Infusion Solution Bag: 2 liters of intravenous normal saline solution will be administered by peripheral IV
Lactated Ringers Solution
n=26 Participants
Participants in this arm will receive two liters of IV Lactated Ringer's solution during their emergency department stay Lactated Ringer Solution: 2 liters of intravenous lactated ringers solution will be administered by peripheral IV
Number of Participants That Filled an ED Prescription
19 Participants
14 Participants

SECONDARY outcome

Timeframe: 7 days

Population: Response rates for the secondary outcomes were 47.4% (n=36) in the NS group and 53.3% (n=42) in the LR group.

Seven days after study enrollment, participants were asked by text message, "Have you returned to the emergency department for the same problem?"

Outcome measures

Outcome measures
Measure
Normal Saline Solution
n=36 Participants
Participants in this arm will receive two liters of IV 0.9% sodium chloride solution during their emergency department stay Normal Saline 0.9% Infusion Solution Bag: 2 liters of intravenous normal saline solution will be administered by peripheral IV
Lactated Ringers Solution
n=42 Participants
Participants in this arm will receive two liters of IV Lactated Ringer's solution during their emergency department stay Lactated Ringer Solution: 2 liters of intravenous lactated ringers solution will be administered by peripheral IV
Number of Participants That Returned to the ED Within 7 Days for the Same Complaint
7 Participants
5 Participants

SECONDARY outcome

Timeframe: 7 days

Population: Response rates for the secondary outcomes were 47.4% (n=36) in the NS group and 53.3% (n=42) in the LR group.

Seven days after study enrollment, participants were asked by text message, "Have you seen another medical provider for the same complaint?".

Outcome measures

Outcome measures
Measure
Normal Saline Solution
n=36 Participants
Participants in this arm will receive two liters of IV 0.9% sodium chloride solution during their emergency department stay Normal Saline 0.9% Infusion Solution Bag: 2 liters of intravenous normal saline solution will be administered by peripheral IV
Lactated Ringers Solution
n=42 Participants
Participants in this arm will receive two liters of IV Lactated Ringer's solution during their emergency department stay Lactated Ringer Solution: 2 liters of intravenous lactated ringers solution will be administered by peripheral IV
Participants That Sought Care From Another Healthcare Provider for the Same Complaint
7 Participants
9 Participants

Adverse Events

Lactated Ringers Solution

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Normal Saline Solution

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Nicholas Mohr

University of Iowa

Phone: 319-384-8285

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place